Bristol Myers Squibb Co. Non-TR

13F holders, Q2 2026 (June 30)
2holders −1
1new positions
2sold out
$0.00avg. 13F price*

At the end of Q2 2026, 2 institutions reported holding Bristol Myers Squibb Co. Non-TR in their 13F filings, down 1 from Q1 2026. 1 opened new positions and 2 sold out. The largest holders were Sterling Capital Management LLC ($0) and GAMMA Investing LLC ($0).

Company
Bristol Myers Squibb Co. Non-TR
CUSIP
604CVR027
Latest filing quarter
Q2 2026

History

Number of 13F holders

01234 Q1 2024: 2Q1 2024Q2 2024: 2Q2 2024Q3 2024: 1Q3 2024Q4 2024: 2Q4 2024Q1 2025: 4Q1 2025Q2 2025: 3Q2 2025Q3 2025: 4Q3 2025Q4 2025: 3Q4 2025Q1 2026: 3Q1 2026Q2 2026: 2Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions1$0
Exits2$11K

All 13F filers, Q1 2026 → Q2 2026: 223 shares bought and 957 shares sold, net −734 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 2 holders

Sterling Capital Management LLC 0.00% No change 109 $0
GAMMA Investing LLC 0.00% New 223 $0

"% of holder's portfolio" is BRISTOL MYERS SQUIBB CO NON-TR's weight in each manager's 13F, not the share of Bristol Myers Squibb Co. Non-TR the manager owns.